HeartBeam Shareholders Reject 3M-Share Equity Plan Increase
BEAT is trading near its 52-week low of $0.481 (1.8% above the low).
Summary
HeartBeam's annual meeting results show shareholders rejected a 3-million-share increase to the equity plan, a setback for management's compensation toolkit amid ongoing financial challenges.
Key Events · Corporate Governance and Compliance · BEAT
-
Equity Plan Expansion Rejected
A proposal to add 3,000,000 shares to the 2022 Equity Incentive Plan failed, with 3,957,529 votes in favor and 7,816,794 against.
-
Director Elections
All seven director nominees were elected, including Branislav Vajdic (President/Founder) and Richard Ferrari, though significant broker non-votes (17.2M) pointed to low retail participation.
-
Auditor Ratification Approved
CBIZ CPAs P.C. was ratified as independent auditor for fiscal 2026, receiving 28.6M votes in favor.
-
Quorum and Turnout
With 29.05M votes represented (52.34% of 55.5M outstanding shares), quorum requirements were comfortably met.
Analysis · BEAT · Industrial Applications And Services
Shareholders voted down a proposal to add 3 million shares to the 2022 Equity Incentive Plan. The rejection limits near-term dilution from equity compensation but may constrain the company's ability to attract and retain talent with stock-based incentives, especially critical given its going concern warning and recent CEO departure.
At the time of this filing, BEAT was trading at $0.49 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $27.3M. The 52-week trading range was $0.48 to $4.00. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.